Metformin in the Elderly: Uses, Benefits, and Side Effects

Metformin in the elderly remains first-line treatment for type 2 diabetes — but it requires more careful dosing than in younger adults. Kidney function dictates the dose, vitamin B12 needs annual checks, GI side effects are managed with extended-release formulations and slow titration, and the medication is held around contrast imaging and acute illness. Despite a longstanding fear of lactic acidosis, the actual risk is small (about 3 to 10 cases per 100,000 patient-years) and rarely a reason to withhold treatment in stable older patients.

Why Metformin Is Still First-Line in Older Adults

• Does not cause hypoglycemia when used alone — a major advantage in elderly patients
• Inexpensive (generic for decades)
• Modest weight-neutral or weight-favorable effect
• Reduces hepatic glucose production rather than increasing insulin
• Possible cardiovascular benefit (observational data; UKPDS subgroup)
• Decades of real-world safety data
• Easy oral administration, no injections, no glucose monitoring required for safety

The ADA Standards of Care continue to recommend metformin as initial therapy unless contraindicated, including in adults over 65.

Renal Dose Adjustments

Kidney function declines with age — average GFR loss is about 1 mL/min/year after age 40. Metformin is renally cleared, so accumulation in renal impairment raises risk of lactic acidosis. The current dosing rules:

eGFR should be checked at least annually in stable patients on metformin and after any acute illness, contrast scan, or medication change that could affect kidneys (ACE inhibitor adjustment, NSAID start, diuretic up-titration).

B12 Deficiency — A Common Silent Side Effect

Metformin interferes with calcium-dependent B12 absorption in the ileum. Prevalence of low B12 rises with duration:

• About 6 percent at 5 years on metformin
• About 10–15 percent at 7 years
• About 20–30 percent at 10+ years

Older adults are doubly at risk because age itself reduces B12 absorption (atrophic gastritis, lower intrinsic factor), and proton pump inhibitor use is common. Symptoms include:

• Fatigue
• Macrocytic anemia
• Peripheral neuropathy (which can be mistaken for diabetic neuropathy)
• Cognitive changes, memory issues
• Glossitis, smooth tongue
• Gait imbalance, falls

Many clinicians check B12 annually in older adults on metformin; some check methylmalonic acid (MMA) when B12 is borderline (200–300 pg/mL). Supplementation is oral cyanocobalamin 1000 mcg daily or intramuscular B12 if absorption is impaired.

GI Side Effects and Tolerability

Up to 25 percent of patients have some GI side effects starting metformin — nausea, diarrhea, abdominal cramping, metallic taste, or loss of appetite. In older adults these can:

• Cause dehydration and AKI (which then raises lactic acidosis risk)
• Worsen sarcopenia and weight loss
• Drive medication discontinuation
• Interact with frailty

Strategies that help:

• Start low — 500 mg once daily with the largest meal
• Titrate slowly — increase by 500 mg every 1–2 weeks
• Use extended-release — much better GI tolerance; once-daily dosing
• Take with food always
• Reassess at 4 and 12 weeks — most GI side effects resolve within a month if not, switch to ER or reduce dose

Lactic Acidosis — Real but Rare

Metformin-associated lactic acidosis (MALA) has been the headline fear for decades. The reality:

• Incidence is about 3–10 cases per 100,000 patient-years
• Mortality if it occurs is high (~30–50%)
• Nearly always associated with a precipitating event — acute kidney injury, sepsis, dehydration, contrast imaging, severe heart failure, hypoxia
• Stable patients on stable doses with stable renal function virtually never develop MALA

Practical precautions:

• Hold metformin 48 hours around iodinated contrast scans (CT with contrast)
• Hold during acute illness with vomiting, diarrhea, or poor intake (“sick day rules”)
• Hold for 24 hours before elective surgery and resume when eating
• Avoid in decompensated heart failure with hypoperfusion
• Avoid in severe liver disease with lactic acidosis risk

Drug Interactions of Note in Older Adults

Benefits Beyond Glucose

• Weight neutrality or modest loss — helpful in obese elders, not always in frail ones
• Possible cardiovascular benefit (UKPDS overweight subgroup)
• Possible cancer signal reduction (observational; not definitive)
• Lower risk of dementia in some cohorts (mixed evidence; ongoing research)
• Pairs well with most other agents — SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, basal insulin

When to Deprescribe Metformin

• eGFR drops below 30
• Persistent intolerable GI side effects despite ER and slow titration
• Significant unintended weight loss in a frail patient
• Symptomatic B12 deficiency unresponsive to supplementation
• Hospice or end-of-life care
• A1C is below the patient’s target with another agent and metformin is redundant

Side Effects to Watch For in Elderly Patients

• GI upset (very common, especially at start)
• Loss of appetite — can worsen frailty
• Metallic taste
• B12 deficiency over years
• Lactic acidosis (rare, usually in illness)
• Dehydration if GI side effects severe
• Drug interactions affecting renal function

Related Reading

For context on overall care in older patients, see diabetes in the elderly and A1C target for elderly. Hypoglycemia is the dominant risk in this population — see diabetes falls prevention in elderly.

The Bottom Line

Metformin in the elderly remains first-line — but with caveats. Dose by kidney function: full dose to eGFR 45, half dose 30–45, stop below 30. Check B12 yearly; long-term users develop deficiency in 20–30 percent of cases at 10+ years. Manage GI side effects with extended-release and slow titration. Hold around contrast, surgery, and acute illness. Lactic acidosis is rare and rarely a reason to withhold in stable patients. Talk to your doctor about whether your dose, monitoring, and sick-day plan match your kidney function and overall health.